KLOW
Get KLOWAlso called: KLOW 80mg
KLOW is a blend made of four small protein-like pieces called peptides. The parts are named GHK-Cu, BPC-157, TB-500, and KPV. It is sold as a white powder in a small bottle for scientists to study in the lab. It is not a medicine and is not approved by the FDA for people or animals.
Scientists look at each part of this blend for different reasons. One part is studied for skin and wound care, one for protecting the stomach, one for helping cells move and repair, and one for calming inflammation. Together, researchers think these pieces might help with healing and repair. But most of these ideas come from lab and animal studies, not from careful tests in people.
There is a lot we still do not know. No one has proven that the blend is safe or works in humans. Mixing four peptides together has not been well studied either. The powder must be kept very cold and used only by trained researchers in a lab. Anyone considering it for their own body should know it is not approved, and its safety is unknown.
Composition
What's in KLOW?
KLOW is a blend — it combines these research peptides, sold together as one item:
The evidence
What the research says about each peptide in KLOW
A blend is only as studied as its parts. The reported findings below come from each peptide’s own research — grouped by compound so you always know which one a finding belongs to, and every claim links to the source it came from.
GHK-Cu
27 sourced studies- Angiogenesis promotion 85/100Rated 85/100Source typePeer-reviewed studyIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Tissue repair and collagen synthesis 60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Increases synthesis of collagen, elastin, and wound healing processes 85/100Rated 85/100Source typePeer-reviewed studyIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Antioxidant activity (ROS reduction) 85/100Rated 85/100Source typePeer-reviewed studyIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Modulation of genes associated with pain and opioid activity 85/100Rated 85/100Source typePeer-reviewed studyIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Stimulates genes 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
Reported routines
- Topical application 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
BPC-157
44 sourced studies- Anti-inflammatory effects 60/100Rated 60/100Source typeSpecialist communityIndependent sources15Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Weight management 60/100Rated 60/100Source typeSpecialist communityIndependent sources5Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Collagen production 60/100Rated 60/100Source typeSpecialist communityIndependent sources5Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Improved sleep quality 60/100Rated 60/100Source typeSpecialist communityIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Obesity treatment 60/100Rated 60/100Source typeEstablished referenceIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Fistula healing 60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
Reported routines
- BPC-157 250–500 mcg/day SC + TB-500 2–5 mg twice weekly for 4–6 week loading, then TB-500 2 mg weekly for 4–8 weeks 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
TB-500
9 sourced studies- Neovascularization 60/100Rated 60/100Source typeSpecialist communityIndependent sources4Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Supports angiogenesis 60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Accelerates wound healing 60/100Rated 60/100Source typeSpecialist communityIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Promotes cell migration and tissue repair via actin sequestration 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Accelerates closure rates in chronic venous ulcers 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Reduces inflammation via anti-inflammatory agent generated by monocytes 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
KPV
4 sourced studies- Anti-inflammatory properties 95/100Rated 95/100Source typePeer-reviewed studyIndependent sources14Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Treatment of Inflammatory Bowel Disease (IBD) / Colitis 90/100Rated 90/100Source typePeer-reviewed studyIndependent sources5Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Anti-inflammatory potential in inflammatory bowel disease 60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Reduces chemotaxis in neutrophils 60/100Rated 60/100Source typeSpecialist communityIndependent sources3Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Anti-inflammatory activity 72/100Rated 72/100Source typeEstablished referenceIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Anti-inflammatory effects in skin and airway tissue 60/100Rated 60/100Source typeSpecialist communityIndependent sources2Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
Reported routines
- 10^-12 M to 10^-3 M (Cosmetic) 72/100Rated 72/100Source typeEstablished referenceIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
Free: The Peptide Stack Cheat-Sheet
See where KLOW fits — the most-used combinations, dosing notes from the research, and what to check before you buy.
No spam. Unsubscribe anytime.
How People Use It
1 reported routine — each line links to the source it came from.
Self-reported & vendor-suggested
Routines shared by users and sellers in forums and product pages — anecdotal, not tested in clinical trials. We show them for completeness, not as a recommendation.
General
- 500 mcg each of TB-500, BPC-157 and KPV + 2.5 mg GHK-Cu once daily SC (range 250–750 mcg each) 60/100Rated 60/100Source typeSpecialist communityIndependent sources1Every claim links to the page it came from, and stronger sources rate higher. Full methodology →↗ source
- Weeks 1–2 — TB-500: 250 mcg | BPC-157: 250 mcg | KPV: 250 mcg | GHK-Cu: 1.25 mg · 7.5 units (0.075 mL)
- Weeks 3–4 — TB-500: 500 mcg | BPC-157: 500 mcg | KPV: 500 mcg | GHK-Cu: 2.5 mg · 15 units (0.15 mL)
- Weeks 5–8 — TB-500: 750 mcg | BPC-157: 750 mcg | KPV: 750 mcg | GHK-Cu: 3.75 mg · 22.5 units (0.225 mL)
- Weeks 9–12 (Maintenance) — TB-500: 500 mcg | BPC-157: 500 mcg | KPV: 500 mcg | GHK-Cu: 2.5 mg · 15 units (0.15 mL)
mg vs mcg: one milligram (mg) equals 1,000 micrograms (mcg) — multiply by 1,000 going from mg to mcg, divide by 1,000 going from mcg to mg. Mixing the two up is a thousand-fold dosing error: 1 mg taken instead of 1 mcg is a 1,000× overdose; 1 mcg instead of 1 mg is a 1,000× underdose. Always double-check the unit label and the decimal place.
Get KLOW
Compare research-grade suppliers with third-party COAs and published purity data. For in-vitro and laboratory research use only — not for human consumption, diagnosis, or treatment.
News
Latest on KLOW
Dated, sourced reporting that mentions KLOW.
Wondering how KLOW pricing compares across suppliers? Our original market data shows the full picture.
See the State of the Peptide Market 2026 →